Pituitary and Neuroendocrinology

With a prevalence of about 10% on MR imaging in the general population, Pituitary tumors are more common than typically thought.  At an equivalent time, many endocrinologists and internists might not have sufficient exposure to deal confidently with a spread of pituitary disorders. If not properly treated, pituitary disorders may end in significant morbidity and lower anticipation. The pituitary is that the center of human sexuality and reproduction. Other parts of the body do most of the work but the pituitary initiates and controls the processes. Due to hormones about 30 and 40% of the population suffers sexual dysfunction at a while in their life. Endocrinology Society studies have reported that CDI is more prevalent in children and older adults (>80 years of age). Primary tumors of the pituitary fossa result in CDI in 50% of children and 30% of adults while head trauma to the posterior pituitary gland accounts for 2% of cases in children and 17% in adults. Hypopituitarism is listed as a rare disorder by the National Institutes of health. To date, there are not any US-based studies on the prevalence and incidence of hypopituitarism. One published report indicated it affects but 200,000 individuals within the US. And therefore the 2010 National Hospital Discharge Survey reported 17,101 US inpatient hospital visits with anhypopituitarism/ hypopituitarism) together of any listed diagnoses, and 749 visits with this because the primary diagnosis. Additionally, the reported average hospital stay was 5.4 days.

    Related Conference of Pituitary and Neuroendocrinology

    September 09-10, 2024

    7th Annual Meeting on Diabetes and Endocrinology

    Paris, France
    September 09-10, 2024

    4th European Endocrinology and Diabetes Congress

    Paris, France
    September 09-10, 2024

    33rd International Diabetes and Healthcare Conference

    Paris, France
    September 25-26, 2024

    5th World Summit on Diabetes Expo

    Rome, Italy
    October 14-15, 2024

    3rd International Summit on Hormonal Disorders

    Madrid, Spain
    November 22-23, 2024

    20th World Congress on Endocrinology & Diabetes

    Amsterdam, Netherlands
    February 24-25, 2025

    34th European Diabetes Congress

    London, UK

    Pituitary and Neuroendocrinology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in